| Literature DB >> 30910528 |
Tomoo Shiba1, Daniel Ken Inaoka2, Gen Takahashi3, Chiaki Tsuge4, Yasutoshi Kido5, Luke Young6, Satoshi Ueda3, Emmanuel Oluwadare Balogun7, Takeshi Nara8, Teruki Honma9, Akiko Tanaka9, Masayuki Inoue10, Hiroyuki Saimoto11, Shigeharu Harada3, Anthony L Moore6, Kiyoshi Kita12.
Abstract
The alternative oxidase (AOX) is a monotopic diiron carboxylate protein which catalyzes the four-electron reduction of dioxygen to water by ubiquinol. Although we have recently determined the crystal structure of Trypanosoma brucei AOX (TAO) in the presence and absence of ascofuranone (AF) derivatives (which are potent mixed type inhibitors) the mechanism by which ubiquinol and dioxygen binds to TAO remain inconclusive. In this article, ferulenol was identified as the first competitive inhibitor of AOX which has been used to probe the binding of ubiquinol. Surface plasmon resonance reveals that AF is a quasi-irreversible inhibitor of TAO whilst ferulenol binding is completely reversible. The structure of the TAO-ferulenol complex, determined at 2.7 Å, provided insights into ubiquinol binding and has also identified a potential dioxygen molecule bound in a side-on conformation to the diiron center for the first time. CrownEntities:
Keywords: Alternative oxidase; Competitive inhibitor; Ferulenol; Proton relay pathway; Trypanosoma brucei; Ubiquinol/dioxygen binding
Mesh:
Substances:
Year: 2019 PMID: 30910528 DOI: 10.1016/j.bbabio.2019.03.008
Source DB: PubMed Journal: Biochim Biophys Acta Bioenerg ISSN: 0005-2728 Impact factor: 3.991